Skip to main contentSkip to breadcrumbsSkip to sub navSkip to doormat

Scientific Advisory Board

With world-class scientists, outstanding students and state-of-the-art technology, the IMP strives to maintain the highest standard of research. To ensure this, the IMP works with internationally recognised scientists from some of the world’s top research institutes and universities to review and steer the IMP’s research through its Scientific Advisory Board (SAB).

The Scientific Advisory Board (SAB) meets with IMP researchers every year to discuss the quality, significance and main focus of research conducted at the IMP. Through this process, the IMP gains important feedback on its work which can then inform future decisions. The SAB and its distinguished members also demonstrate the strong ties between the IMP and other world-class research institutions.

Current SAB Members

Leslie Vosshall, Chair - since 2013
Rockefeller University, New York (USA)

Angelika Amon - since 2009
MIT, Cambridge (USA)

Hans Clevers - since 2015
Hubrecht Institute, Utrecht (Netherlands)

Michael Häusser - since 2015
University College London, United Kingdom

Norbert Kraut - since 2011
Boehringer Ingelheim RCV GmbH, Vienna (Austria)

Dan Littman - since 2009
NYU Langone Medical Center, New York (USA)

Ruslan Medzhitov - since 2016
Yale School of Medicine/HHMI, New Haven (USA)

Tom Rapoport - since 2011
Harvard Medical School, Boston (USA)

Dirk Schübeler - since 2014
Friedrich Miescher Institute for Biomedical Research, Basel (Switzerland)

Former SAB Members

2009-2014
Anton Berns
Netherlands Cancer Institute
Amsterdam, The Netherlands

2009-2014
Tobias Bonhoeffer
Max-Planck-Institute of Neurobiology
Martinsried, Germany

2008-2013
Venki Ramakrishnan
MRC Laboratory of Molecular Biology
Cambridge, United Kingdom

2009-2013
Ewan Birney
European Molecular Biology Laboratory EMBL-EBI
Hinxton, United Kingdom

2006-2012
Cornelia Bargmann
Rockefeller University
New York, USA

2004-2012
Wolfgang Rettig
Boehringer Ingelheim GmbH
Ingelheim, Germany

2004-2012
Rudolf Jaenisch
Whitehead Institute
Cambridge, USA

2004-2009
Andreas Barner
Boehringer Ingelheim GmbH
Ingelheim, Germany

2002-2009
Frederick W. Alt
Harvard Medical School
Boston, USA

2003-2008
Titia de Lange
Rockefeller University
New York, USA

2001-2008
Steve McKnight
Southwestern Medical Center
Dallas, USA

2004-2007
Gregory A. Petsko
Brandeis University
Waltham, USA

2001-2006
Tyler Jacks
MIT Department of Biology
Cambridge, USA

1998-2005
David Lane
University of Dundee
Dundee, United Kingdom

2005
Georg Stingl
Austrian Academy of Sciences
Vienna, Austria

1999-2004
Herbert Jäckle
Max-Planck-Institute for Biophysical Chemistry
Göttingen, Germany

1998-2003
Janet Rossant
Samuel Lunenfeld Research Institute
Toronto, Canada

1987-2003
Peter Swetly
Boehringer Ingelheim Austria
Vienna, Austria

1996-2002
Martin Raff
University College London
London, United Kingdom

1995-2001
Tim Hunt
ICRF Clare Hall Laboratories
South Mimms, United Kindom

1998-2001
Bernd Wetzel
Boehringer Ingelheim GmbH
Ingelheim, Germany

1993-2000
Nick Hastie
MRC Human Genetics Unit
Edinburgh, United Kingdom

1991-1999
Michael Bishop
University of California in San Francisco
San Francisco, USA

1987-1998
Gottfried Schatz
Biozentrum der Universität Basel
Basel, Switzerland

1993-1998
Tadatsugu Taniguchi
University of Tokyo
Tokyo, Japan

1994-1997
Christoph Hohbach
Boehringer Ingelheim GmbH
Ingelheim, Germany

1987-1997
Robert Weinberg
Whitehead Institute
Cambridge, USA

1988-1993
Francois Cuzin
Universitè Nice
Nice, France

1987- 1993
Piet Borst
Netherlands Cancer Institute
Amsterdam, Netherlands

1988-1992
Dave Goeddel
Genentech Inc.
San Francisco, USA

1988-1992
John Mendelsohn
Cornell University/Sloan Kettering Institute/ MD
Anderson Cancer Center; Ithaca/New York/Houston, USA

1987-1989
David Baltimore
Rockefeller University
New York, USA